A Pilot Study Highlighting Differences in Pharmacists' Perceptions Regarding Use of Pharmacogenetic Information in their Profession (in Louisville Metro Area) Based on Practice Settings


  • Midway College School of Pharmacy, Paintsville, KY41240, United States
  • Sullivan University College of Pharmacy, Louisville, KY40205, United States
  • Touro College of Pharmacy, New York, 10027, United States
  • University of Houston College of Pharmacy, Houston, TX77204, United States


The aim of this study was to highlight differences in pharmacist's perceptions regarding use of pharmacogenetic information in their professional activities based on their practice settings. A survey was electronically administered using the Survey Monkey to 48 practicing pharmacists in the hospitals and non - hospital study groups which include community pharmacy and manage d care around the metro Louisville, Kentucky area Barring minor deviations, there was overall homogeneity in our pilot study group's general knowledge, overall confidence in pharmacogenetics and perceptions about possible impact of this emerging fie ld in their profession, regardless of their professional practice environment. Overall low to moderate levels of pharmacists' confidence in pharmacogenetics and related areas even a decade after completion of Human Genome Project (HGP) seems to be a matter of concern.


Pharmacogenetics, Human Genome Project.

Subject Discipline

Pharmacy and Pharmacology

Full Text:


Swen JJ, Huizinga TW, Gelderblom H, De Vries E, Assesdelft W and Kirchaeiner J, Translating Phamacogenomics: Challenges on the road to the clinic, PLoS Med, 2007, 4(8),e209. doi:10.1371/journal.pmed.0040209

Evans W, Relling M, Moving towards individualized medicine, Nature, 2004,429, 464-468.

Foxhall K, Pharmacogenetics: Pharmacists should own it, not fear it, Drug Topics, 2008, 4-5.

Teagarden JR, Pharmacogenomics and its potential uses in managed care pharmacy, Hospital Pharmacy 2006, 4(5),477-481.

El-IbiarySY, Cheng C and Alldredge B, Potential roles for pharmacists in pharmacogenetics,JAPhA, 2008, 48, e21e32

Sansgiry SS, The Human Genome Project: Assessing Confidence in Knowledge and Training Requirements for Community Pharmacists, AJPE, 2003, 67,1-9

Brock TP, Faulkner CM, Williams DM and Smith SR, Continuing education programs in pharmacogenomics for pharmacists, American Journal Health-Syst Pharm, 2002, 59,722-725

Ethical, Legal and Social Implications (ELSI) Program: Areas, Public and professional Education, National Human Genome Research Institute, http://www.genome.gov/page.cfm, Accessed January 09, 2010

Report of the ASHP Task force on science, American Journal Health-Syst Pharm,1998,55,2519-2524

Council on Professional Affairs: policy recommendations, American Society of

Health-Syst Pharm, Pharmacists. www.ashp.org/public/hq/policy/crep_2000/ m-copa.htm, Accessed Jan 03, 2010

ASHP leadership agenda, .American Journal Health Syst Pharm.2001,58,1523-1524’

LangevinBC,Pharmacogenomics:tailoringdr ug therapy, JAPhA, 1999, 39, 597-598

Mcleod H et al, Pharmacogenomics: Applications to Patient Care, Mcleod H, 2nd Edition, ACCP,Lenexa, KS, 2009

Latif,DAand McKay,AB, Pharmacogenetics and Pharmacogenomics instruction in Colleges and Schools of Pharmacy in the United States, AJPE, 2005, 69(2),23-27


  • There are currently no refbacks.